Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients

BACKGROUND: To improve identification of patients with cutaneous squamous cell carcinoma (SCC) at high risk for metastatic disease, the DecisionDx-SCC assay, a prognostic 40-gene expression profile (40-GEP) test, was developed and validated. The 40-GEP assay utilizes RT-PCR gene expression analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Borman, Sherri, Wilkinson, Jeff, Meldi-Sholl, Lauren, Johnson, Clare, Carter, Kelsey, Covington, Kyle R., Fitzgerald, Alison L., Kurley, Sarah J., Farberg, Aaron S., Goldberg, Matthew S., Monzon, Federico A., Oelschlager, Kristen, Cook, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876832/
https://www.ncbi.nlm.nih.gov/pubmed/35216597
http://dx.doi.org/10.1186/s13000-022-01211-w

Ejemplares similares

Ejemplares similares